News Library
- Afraxis, Inc. and Servier Announce a collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders30/04/2013
- Vernalis and Servier Extend Oncology Collaboration06/03/2013
- Achievement of new milestones in Galapagos alliances with Servier06/03/2013
- XOMA Announces Encouraging Interim Results From Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris20/02/2013
- The UIP/Servier Research Fellowship 2013/2015 - Call for application04/01/2013
- Valdoxan® (agomelatine): Award of the Italian Prix Galien 2012 03/12/2012
- XOMA announces Servier has initiated a proof-of-concept Gevokizumab study in patients with a history of acute coronary syndrome29/11/2012
- Professor Caroline Dive, University of Manchester, winner of the 2012 Pasteur-Weizmann/Servier Prize28/11/2012
- Servier Research Grant in Hypertension: call for application28/11/2012
- G.B. Morgagni Prizes 2012 Winners20/11/2012
- XOMA Announces Perindopril and Amlodipine Fixed-Dose Combination Meets Primary Endpoint in Phase 3 PATH Trial20/11/2012
- NovAliX and Servier Collaborate in Early Discovery Research Program27/10/2012
- Information about Valdoxan for health care professionals10/10/2012
- Information about Valdoxan for patients10/10/2012
- Servier-Ruijin Talent Development and Scientific Exchanges08/10/2012
- Celebrating the 10th Anniversary of Servier Tianjin Pharmaceutical Company08/10/2012
- XOMA Initiates Safety and Efficacy Study of Gevokizumab in PatientXOMA Initiates Safety and Efficacy Study of Gevokizumab in Patients with Non-infectious Uveitis Currently Controlled by Systemic Treatments with Non-infectious Uveitis03/10/2012
- Servier concludes a collaboration and license agreement with EOS for its antitumor drug E-381001/10/2012
- The Florey Institute of Neuroscience and Mental Health and Servier to collaborate on a Novel Target for Alzheimer’s Disease28/09/2012
- XOMA Announces Servier has Initiated Phase 3 Gevokizumab Trial in Patients with Behçet’s Uveitis 27/09/2012
- Servier and MacroGenics Enter Broad Strategic Alliance to Develop and Commercialize Three Anti-Cancer DART™ Products20/09/2012
- Servier Announces Manufacturing Agreement with Boehringer Ingelheim03/08/2012
- The winner of the 2011 Servier/UIP (Union Internationale de Phlébologie) Research Fellowship is Doctor Győző SZOLNOKY19/07/2012
- Renewal and extension of the collaborative contract between Servier and Genepep for the development of chemical protein synthesis10/07/2012
- IOF-SERVIER Research Grant: the 2012 winner is Mark EDWARDS29/06/2012
- The European Medicines Agency confirms the positive benefit-risk balance of Vastarel* as add-on to first line therapy in the treatment of stable angina 22/06/2012
- Collaboration between Servier and Monash Institute of Pharmaceutical Sciences (MIPS) on G‐Protein Coupled Receptors07/03/2012
- Servier and BioInvent enter Oncology collaboration12/01/2012
- Servier and MacroGenics Enter Development and Commercialization Agreement for Novel Anti-Cancer Drug22/12/2011
- Servier and Galapagos initiate strategic alliance for innovative treatments in oncology11/11/2011
- The Servier Award in Microcirculation 2011 winner is Dr Abigail WOODFIN07/11/2011
- Servier and Miragen Sign Partnership Agreement for the Research, Development and Commercialization of MicroRNA-targeting Drugs for Cardiovascular Disease02/11/2011
- Servier exercises option on jointly-discovered Ampakine® CX1632/S 47 445, an innovative compound in clinical development for alzheimer’s disease18/10/2011
- Servier and Intercept Pharmaceuticals Announce Agreement in Type 2 Diabetes09/08/2011
- 2011 Jean Delay Prize Winner: Professor Kenneth S. Kendler, USA20/07/2011
- Cancer and monoclonal antibodies: “BioRéalités” acquisition by SERVIER07/07/2011
- IOF-SERVIER 2012 Young Investigator Research Grant - Application information21/06/2011
- Servier partners Singapore Immunology Network to develop anti-cancer drugs that nip breast cancer in the bud28/04/2011
- Fondamental-Servier Grants for 201118/04/2011
- ISHR-ES SERVIER Research Fellowship 2010 awarded to Dr Atsuko KASAHARA25/01/2011
- Morgagni Prizes 2010 Winners18/01/2011
- ECTS/Servier Fellowship 2012 - Call for application11/01/2011
- SERVIER announces Joint Development and Commercialization with XOMA on Novel Therapeutics for Orphan Disease06/01/2011
- Servier and Vernalis Achieve Research Milestone in 2nd Oncology Collaboration25/10/2010
- The G.B. MORGAGNI Prizes 2012 - Call for application24/01/2010
- Servier reaches milestones in its osteoarthritis alliance with Galapagos20/07/2009